Pharmaceutical Market Access in Developed Markets PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Pharmaceutical Market Access in Developed Markets PDF full book. Access full book title Pharmaceutical Market Access in Developed Markets by Güvenç Koçkaya. Download full books in PDF and EPUB format.
Author: Güvenç Koçkaya Publisher: SEEd ISBN: 8897419747 Category : Medical Languages : en Pages : 325
Book Description
Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. It covers a group of activities intended to provide access to the appropriate medicine for the appropriate group of patients at the appropriate price (in most countries). Market Access may also be seen as activities that support the management of potential barriers, such as non-optimal price and reimbursement levels, the restriction of the scope of prescribing for the drug or complicated prescription writing or funding procedures. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in our previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics, industry personnel, government workers, and decision makers understand the environment in developed markets.
Author: Güvenç Koçkaya Publisher: SEEd ISBN: 8897419747 Category : Medical Languages : en Pages : 325
Book Description
Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. It covers a group of activities intended to provide access to the appropriate medicine for the appropriate group of patients at the appropriate price (in most countries). Market Access may also be seen as activities that support the management of potential barriers, such as non-optimal price and reimbursement levels, the restriction of the scope of prescribing for the drug or complicated prescription writing or funding procedures. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in our previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics, industry personnel, government workers, and decision makers understand the environment in developed markets.
Author: Mark V. Pauly Publisher: Elsevier ISBN: 0444535926 Category : Business & Economics Languages : en Pages : 1149
Book Description
"As a relatively new subdiscipline of economics, health economics has made many contributions to areas of the main discipline, such as insurance economics. This volume provides a survey of the burgeoning literature on the subject of health economics." {source : site de l'éditeur].
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309468086 Category : Medical Languages : en Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Walter A. Garcia-Fontes Publisher: Springer Science & Business Media ISBN: 8493806277 Category : Medical Languages : en Pages : 105
Book Description
Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
Author: Yves Bourdet Publisher: Taylor & Francis ISBN: 1040166563 Category : Business & Economics Languages : en Pages : 383
Book Description
In the years prior to this book being originally published in 1992, the study of industrial economics had been dominated by the USA. While there was a fund of theoretical and empirical knowledge relating to the US experience, this is not always relevant in the context of Europe. With its considerable national market the USA developed competition policies that differ from those in the smaller economies of European countries. This collection of essays looks at the market behaviour of an economy more open to international competition. The industrial organization of Sweden provides the ideal representation of smaller economies that can be applied to the other economies of western Europe. The contributors apply different analytical approaches to assess direct and indirect forms of market power. Some papers draw on econometric cross-sectional models exploring the scope of market power and the role of international competition. Others look at specific markets investigating the formation of market power – its costs to consumers and the role of lobbying groups and the political sphere: case studies include the domestic car, white goods, pharmaceutical goods, food, textile and air transport markets. The book also contains papers that examine the role of competition policy towards restrictive practices and mergers in curbing market power and promoting economic efficiency. This book will be of interest to those studying industrial economics and international business and marketing.
Author: Kamil Feridun Turkman Publisher: Springer ISBN: 3319070282 Category : Mathematics Languages : en Pages : 255
Book Description
This book offers a useful combination of probabilistic and statistical tools for analyzing nonlinear time series. Key features of the book include a study of the extremal behavior of nonlinear time series and a comprehensive list of nonlinear models that address different aspects of nonlinearity. Several inferential methods, including quasi likelihood methods, sequential Markov Chain Monte Carlo Methods and particle filters, are also included so as to provide an overall view of the available tools for parameter estimation for nonlinear models. A chapter on integer time series models based on several thinning operations, which brings together all recent advances made in this area, is also included. Readers should have attended a prior course on linear time series, and a good grasp of simulation-based inferential methods is recommended. This book offers a valuable resource for second-year graduate students and researchers in statistics and other scientific areas who need a basic understanding of nonlinear time series.
Author: Min Ding Publisher: Springer Science & Business Media ISBN: 1461478014 Category : Medical Languages : en Pages : 763
Book Description
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.
Author: Mario Glowik Publisher: Walter de Gruyter ISBN: 3486599763 Category : Business & Economics Languages : en Pages : 296
Book Description
Im ersten Teil des Buches werden einschlägige Internationalisierungstheorien vorgestellt. Neben traditionellen Konzepten der Internationalisierung (z.B. Produktlebenszyklusansatz von Vernon, Uppsala Modell und Porter’s Diamant Ansatz) wird den moderneren Netzwerkansätzen (z.B. Systemansatz, New Venture bzw. Born Global und Entrepreneurkonzepte) besonderer Stellenwert eingeräumt. Im zweiten Teil werden Alternativen des internationalen Markteintritts (z.B. Exporte, Franchising, Joint Ventures, Auftragsproduktion und Direktinvestitionen) mit Bezug auf elementare Entscheidungsdeterminanten aus Sicht der Unternehmensführung, wie hierarchische Kontrolle, Marktnähe, Investitionsrisiko und dem Faktor Zeit, erläutert. Im empirischen Teil des Buches werden im Resultat einer Langzeituntersuchung Fallstudien asiatischer Firmen der Konsumentenelektronikindustrie, wie beispielsweise Samsung, Sony, Sharp, Matsushita (Panasonic), LG Electronics und TCL China, deren Organisationsstrukturen, Unternehmenskulturen, jeweilige Umsatz- und Gewinnentwicklung, sowie strategische Konzepte zur Marktdurchdringung in Europa erläutert. Ein Schwerpunkt bildet die Darstellung interner (z.B. diversifizierte Geschäftsfelder, vertikale Produktionstiefe) und externer Netzwerke (z.B. Joint Ventures, Zuliefer- und Abnehmercluster sowie Kapitalbeteiligungen) die aus Sicht des Autors wesentlich dazu beitragen, dass sich asiatische Unternehmen im Vergleich zu ihren europäischen Wettbewerbern der Fernsehgeräteindustrie (z.B. Grundig, Thomson oder Philips) in den letzten beiden Jahrzehnten wesentlich erfolgreicher am Markt positioniert haben. In diesem Zusammenhang werden Ziele, Erfolgsfaktoren sowie der strategische Einfluss der involvierten Partnerfirmen, einerseits in bilateralen japanischen Joint Ventures und andererseits, in europäisch - asiatischen Joint Ventures, über einen Zeitverlauf von mehreren Jahren untersucht. Das Buch liefert komplexe Hintergrundinformationen zur Entwicklung des europäischen Fernsehgerätemarktes. Im Ergebnis wird unter anderem nachgewiesen, dass Unternehmen mit den intensivsten Netzwerkaktivitäten auch gleichzeitig technologische Marktführer in ihrem Segment sind. Die Weiterentwicklung der Netzwerktheorie und die ausführlichen Fallstudien mit hohem Aktualitätsanspruch, der wichtigsten asiatischen Unternehmen der Konsumentenelektronikindustrie, prägen den besonderen Wert dieser Publikation. Auf der Basis der gewonnenen Erkenntnisse können darüber hinaus Chancen- und Risikopotentiale für andere europäische Branchen (z.B. Automobilbau) abgeleitet werden. Das in Englisch geschriebene Buch eignet sich hervorragend für Studierende international ausgerichteter Bachelor-, Master- und MBA Studiengänge und bietet vor dem Hintergrund eines globalisierten Wettbewerbs darüber hinaus relevante Industrieeinblicke für interessierte Entscheidungsträger aus Politik und Wirtschaft. The first part of the book introduces relevant theories of internationalization. In addition to traditional concepts of internationalization (e.g., the product life-cycle approach of Vernon, the Uppsala model, and Porter's diamond approach), particular attention is paid to the more modern network approaches of internationalization (e.g., systems, new venture/born global, and entrepreneur concepts). In the second part, alternatives for international market entry (e.g., exports, franchising, joint ventures, contract manufacturing, and foreign direct investments) are explained. These market entry modes are categorized according to decision determinants, such as hierarchical control, proximity to the market, risk of investment, and the factor of time, which are important from the point of view of the corporate management involved in international business. The empirical part of this publication, which is the result of a longitudional study, consists of case studies of Asian firms doing business in the consumer electronics industry. The cases of Samsung, Sony, Sharp, Matsushita (Panasonic), LG Electronics, and TCL China provide fundamental insights into the firms’ organizational structures, corporate cultures, respective sales volume, and earnings performance as well as strategic concepts for their market penetration in Europe. A main emphasis is placed on an understanding of internal firm networks (e.g., diversified business fields and vertical production depth) and external firm networks (e.g., joint ventures, supplier and buyer clusters as well as mutual capital interests). From the author’s view, these network grids fundamentally contribute to the fact that Asian firms have more successfully positioned themselves in the market within the last two decades compared to their European competitors in the television set industry (e.g. Grundig, Thomson, or Philips). The networking aims and success factors as well as the changing strategic influence over the years of the partner firms both in bilateral Japanese joint ventures and in European-Asian joint ventures are examined. The book provides complex background information about the development of the European television set market. The analysis demonstrates that firms holding the position of technological market leaders in their segment simultaneously indicate the most intensive network activities. The further development of the network theory and the detailed and up-to-date case studies of the most important Asian enterprises in the consumer electronics industry contribute to the value of this publication. Furthermore, on the basis of the knowledge gained from this study, chances and risk potentials can be derived for other European industries (e.g., automotive). The book, written in English, is suitable for internationally oriented bachelor’s, master’s and MBA programs. Additionally, against the background of worldwide competition, the publication at hand offers relevant industry insights for interested political and economic decision makers.
Author: Centers of Disease Control Publisher: World Health Organization ISBN: 9289051701 Category : Medical Languages : en Pages : 148
Book Description
What are public health services? Countries across Europe understand what they are or what they should include differently. This study describes the experiences of nine countries detailing the ways they have opted to organize and finance public health services and train and employ their public health workforce. It covers England France Germany Italy the Netherlands Slovenia Sweden Poland and the Republic of Moldova and aims to give insights into current practice that will support decision-makers in their efforts to strengthen public health capacities and services. Each country chapter captures the historical background of public health services and the context in which they operate; sets out the main organizational structures; assesses the sources of public health financing and how it is allocated; explains the training and employment of the public health workforce; and analyses existing frameworks for quality and performance assessment. The study reveals a wide range of experience and variation across Europe and clearly illustrates two fundamentally different approaches to public health services: integration with curative health services (as in Slovenia or Sweden) or organization and provision through a separate parallel structure (Republic of Moldova). The case studies explore the context that explain this divergence and its implications. This study is the result of close collaboration between the European Observatory on Health Systems and Policies and the WHO Regional Office for Europe Division of Health Systems and Public Health. It accompanies two other Observatory publications Organization and financing of public health services in Europe and The role of public health organizations in addressing public health problems in Europe: the case of obesity alcohol and antimicrobial resistance (both forthcoming).
Author: Güvenç Koçkaya
Author: Güvenç Koçkaya
Author: Mark V. Pauly
Author: National Academies of Sciences, Engineering, and Medicine
Author: Walter A. Garcia-Fontes
Author: Yves Bourdet
Author: Kamil Feridun Turkman
Author: Min Ding
Author: Mario Glowik
Author: United States. Task Force on Prescription Drugs
Author: Centers of Disease Control